Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Novo Nordisk A/S (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
NVO
New York
2834
https://www.novonordisk.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Novo Nordisk A/S (ADR)
Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
- May 3rd, 2024 9:07 pm
Novo Nordisk A/S (NYSE:NVO) Q1 2024 Earnings Call Transcript
- May 3rd, 2024 7:15 pm
Analyst unveils Amgen stock price target after weight-loss drug data
- May 3rd, 2024 6:53 pm
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
- May 3rd, 2024 5:48 pm
Weight-loss drug competition heats up. Is Wegovy in trouble?
- May 3rd, 2024 3:35 pm
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
- May 3rd, 2024 3:29 pm
Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
- May 3rd, 2024 2:51 pm
FTC Seeks More Information on $16.5 Billion Novo-Catalent Deal
- May 3rd, 2024 1:50 pm
US FTC seeks more information on Novo Nordisk parent-Catalent deal
- May 3rd, 2024 12:58 pm
UPDATE 2-US FTC seeks more information on Novo Nordisk parent-Catalent deal
- May 3rd, 2024 12:36 pm
Novo Slides as Amgen Fuels Obesity Drug Competition Fears
- May 3rd, 2024 11:47 am
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
- May 3rd, 2024 11:04 am
This Is a Huge Sigh of Relief for Novo Nordisk Investors
- May 3rd, 2024 11:00 am
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
- May 3rd, 2024 10:36 am
Here’s How Novo Holdings’ Catalent (CTLT) Acquisition Affects Laughing Water Capital
- May 3rd, 2024 8:02 am
Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
- May 2nd, 2024 10:01 pm
Novo Nordisk slides while Moderna pops: Tale of two pharma stocks
- May 2nd, 2024 8:17 pm
Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK
- May 2nd, 2024 8:08 pm
Novo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast
- May 2nd, 2024 8:02 pm
Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.
- May 2nd, 2024 5:08 pm
Scroll